<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE HTML>
<html xml:lang="en" xmlns="http://www.w3.org/1999/xhtml" lang="en">
  <head>
    <meta content="text/html;charset=utf-8" http-equiv="Content-Type"/>
    <title>AntibioticSensitivityInterpretation FHIR - US Veterans Health Administration FHIR Map Set Implementation Guide v1.5.11</title>

    <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
    <meta name="author" content="http://hl7.org/fhir"/>

    <link href="fhir.css" rel="stylesheet"/>

    <!-- Bootstrap core CSS -->
    <link href="assets/css/bootstrap-fhir.css" rel="stylesheet"/>

    <!-- Project extras -->
    <link href="assets/css/project.css" rel="stylesheet"/>
    <link href="assets/css/pygments-manni.css" rel="stylesheet"/>
    <link href="assets/css/jquery-ui.css" rel="stylesheet"/>
  	<link href="assets/css/prism.css" rel="stylesheet" />
  	<link href="assets/css/cqf.css" rel="stylesheet" />
    <!-- Placeholder for child template CSS declarations -->
    <link href="assets/css/va-maps.css" rel="stylesheet"/>

    <script type="text/javascript" src="fhir-table-scripts.js"> </script>

    <!-- HTML5 shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!--[if lt IE 9]>
    <script src="assets/js/html5shiv.js"></script>
    <script src="assets/js/respond.min.js"></script>
    <![endif]-->

    <!-- Favicons -->
    <link rel="fhir-logo" sizes="144x144" href="assets/ico/icon-fhir-144.png"/>
    <link rel="fhir-logo" sizes="114x114" href="assets/ico/icon-fhir-114.png"/>
    <link rel="fhir-logo" sizes="72x72" href="assets/ico/icon-fhir-72.png"/>
    <link rel="fhir-logo" href="assets/ico/icon-fhir-57.png"/>
    <link rel="shortcut icon" href="assets/ico/favicon.png"/>
  </head>
  <body onload="document.body.style.opacity='1'">

	  <script src="assets/js/prism.js"></script>
    <script type="text/javascript" src="assets/js/mermaid.js"></script>
    <script type="text/javascript" src="assets/js/mermaid-init.js"></script>
    <style type="text/css">h2{--heading-prefix:"10.141"}
    h3,h4,h5,h6{--heading-prefix:"10.141"}</style>
    <div id="segment-header" class="segment">  <!-- segment-header -->
      <div class="container">  <!-- container -->

        <!-- Placeholder for child template header declarations -->

<div id="project-nav">
    <a id="family-logo" no-external="true" href="https://va.gov"><img height="50" alt="Visit the VA website"
        src="assets/images/va.png" /> </a>
</div>

<div id="family-nav">
    <a id="family-logo" no-external="true" href="http://hl7.org/fhir"><img height="50" alt="Visit the FHIR website" src="assets/images/fhir-logo-www.png"/> </a>
</div>

        <div id="ig-status">
          <p><span style="font-size:12pt;font-weight:bold">US Veterans Health Administration FHIR Map Set Implementation Guide</span>
            <br/>
            <span style="display:inline-block;">1.5.11 - 250601



  <img alt="United States of America flag" src="assets/images/usa.svg" height="16" title="United States of America"/>


            </span>
          </p>
        </div>
      </div> <!-- /container -->
    </div>  <!-- /segment-header -->

    <div id="segment-navbar" class="segment">  <!-- segment-navbar -->
      <div id="stripe"> </div>
      <div class="container">  <!-- container -->
        <!-- HEADER CONTENT -->

        <nav class="navbar navbar-inverse">
          <!--status-bar-->
          <div class="container">
            <button data-target=".navbar-inverse-collapse" class="navbar-toggle" data-toggle="collapse" type="button">
              <span class="icon-bar"> </span>
              <span class="icon-bar"> </span>
              <span class="icon-bar"> </span>
            </button>
            <a class="navbar-brand hidden" href="http://hl7.org/fhir/R4/index.html">FHIR</a>
            <div class="nav-collapse collapse navbar-inverse-collapse">
              <!-- menu.xml  -->

<ul xmlns="http://www.w3.org/1999/xhtml" class="nav navbar-nav">
  <li>
    <a href="index.html">Home</a>
  </li>
  <li class="dropdown">
    <a data-toggle="dropdown" href="#" class="dropdown-toggle">Background
      <b class="caret"></b>
    </a>
    <ul class="dropdown-menu">
      <li>
        <a href="process.html">Process</a>
      </li>
      <li>
        <a href="profileHierarchy.html">Profile Hierarchy</a>
      </li>
      <li>
        <a href="designPatterns.html">FHIR Design Patterns</a>
      </li>
      <li>
        <a href="classes.html">Classes</a>
      </li>
    </ul>
  </li>
  <li class="dropdown">
    <a data-toggle="dropdown" href="#" class="dropdown-toggle">Use Cases
      <b class="caret"></b>
    </a>
    <ul class="dropdown-menu">
      <li>
        <a href="overview.html">Overview</a>
      </li>
      <li>
        <a href="debtPortal.html">Debt Portal</a>
      </li>
      <li>
        <a href="vitals.html">Vitals</a>
      </li>
    </ul>
  </li>
  <li class="dropdown">
    <a data-toggle="dropdown" href="#" class="dropdown-toggle">FHIR Artifacts
      <b class="caret"></b>
    </a>
    <ul class="dropdown-menu">
      <li>
        <a href="artifacts.html">Artifacts</a>
      </li>
      <li>
        <a href="extensions.html">Extensions</a>
      </li>
      <li>
        <a href="mustSupport.html">Must Support</a>
      </li>
    </ul>
  </li>
  <li>
    <a href="changes.html">Changes</a>
  </li>
  <li>
    <a href="history.html">History</a>
  </li>
  <li>
    <a href="mapset-qa.html">MapSet QA</a>
  </li>
</ul>
            </div>  <!-- /.nav-collapse -->
          </div>  <!-- /.container -->
        </nav>  <!-- /.navbar -->
      <!-- /HEADER CONTENT -->
      </div>  <!-- /container -->
    </div>  <!-- /segment-navbar -->
    <!--status-bar-->

    <div id="segment-breadcrumb" class="segment">  <!-- segment-breadcrumb -->
      <div class="container">  <!-- container -->
        <ul class="breadcrumb">
          <li><a href='toc.html'><b>Table of Contents</b></a></li><li><a href='artifacts.html'><b>Artifacts Summary</b></a></li><li><b>AntibioticSensitivityInterpretation FHIR</b></li>

          <span style="float:right;">

            <a href="ValueSet-allergyVerificationStatus-vista.ttl.html">&lt;prev</a> | 

            <a href="#bottom">bottom</a>

          | <a href="ValueSet-AntibioticSensitivityInterpretation-testing.html">next&gt;</a>

          </span>

        </ul>
      </div>  <!-- /container -->
    </div>  <!-- /segment-breadcrumb -->

    <a name="top"> </a>
    <div id="segment-content" class="segment">  <!-- segment-content -->
      <div class="container">  <!-- container -->
        <div class="row">
          <div class="inner-wrapper">

<div class="col-12">
  <!--ReleaseHeader--><p id="publish-box">Publication Build: This will be filled in by the publication tooling</p><!--EndReleaseHeader-->
  








<ul class="nav nav-tabs">

  <li class="active">
    <a href="#">Narrative Content</a>
  </li>




  
    <li>
      <a href="ValueSet-AntibioticSensitivityInterpretation.json.html">JSON</a>
    </li>
  




</ul>

  <a name="root"> </a>
  <h2 id="root">ValueSet: AntibioticSensitivityInterpretation FHIR

  </h2>
  <table class="colsi">

    <tr>
      <td colspan="4"><i>Official URL</i>: <span class="copy-text">http://va.gov/fhir/ValueSet/AntibioticSensitivityInterpretation<button title="Click to copy URL" class="btn-copy" data-clipboard-text="http://va.gov/fhir/ValueSet/AntibioticSensitivityInterpretation"/></span>
      </td>
      <td><i>Version</i>:
      <span class="copy-text">1.5.11<button title="Click to copy versioned URL" class="btn-copy" data-clipboard-text="http://va.gov/fhir/ValueSet/AntibioticSensitivityInterpretation|1.5.11"/></span>
      </td>
    </tr>

    <tr>







      <td colspan="4">
        
          Active
          
            as of 2025-05-08
          
        
      </td>



      <td><i>Computable Name</i>: <span style="font-family: monospace;">AntibioticSensitivityInterpretation</span></td>
    </tr>




  </table>

<p>
<p>FHIR Target ValueSet for Terminology Maps <a href="ConceptMap-VF-AntibioticSensitivityInterpretation.html">VF_AntibioticSensitivityInterpretation</a></p>

</p>


  <p>
    <b>References</b>
  </p>
  
<ul>
 <li><a href="StructureDefinition-LabObservationMicrobiologyBacteriologyObservation.html">Lab Observation: Microbiology Bacteriology Observation</a></li>
</ul>


  <!-- insert intro if present -->
  



<div style="display:inline-block" markdown="1">

<blockquote>
  <p>This value set contains the valid values for FHIR. The source values from VistA are mapped to these values in the linked ConceptMap.</p>
</blockquote>

</div>




  <a name="definition"> </a>

<!-- Content Logical Definition heading in the fragment -->
  <h3>Logical Definition (CLD)</h3>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ValueSet AntibioticSensitivityInterpretation</b></p><a name="AntibioticSensitivityInterpretation"> </a><a name="hcAntibioticSensitivityInterpretation"> </a><a name="AntibioticSensitivityInterpretation-en-US"> </a>
<ul><li>Include these codes as defined in <a href="http://terminology.hl7.org/6.3.0/CodeSystem-v3-ObservationInterpretation.html"><code>http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href="http://terminology.hl7.org/6.3.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-I">I</a></td><td>Intermediate</td><td>Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with uncertain therapeutic effect. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized\_Terminolo.htm) Projects: ISO 20776-1, ISO 20776-2<br/><br/>\[Note 1: Bacterial strains are categorized as intermediate by applying the appropriate breakpoints in a defined phenotypic test system.\]<br/><br/>\[Note 2: This class of susceptibility implies that an infection due to the isolate can be appropriately treated in body sites where the drugs are physiologically concentrated or when a high dosage of drug can be used.\]<br/><br/>\[Note 3: This class also indicates a "buffer zone," to prevent small, uncontrolled, technical factors from causing major discrepancies in interpretations.\]<br/><br/>\[Note 4: These breakpoints can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).\]</td></tr><tr><td><a href="http://terminology.hl7.org/6.3.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-R">R</a></td><td>Resistant</td><td>Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic failure. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized\_Terminolo.htm) Projects: ISO 20776-1, ISO 20776-2<br/><br/>\[Note 1: Bacterial strains are categorized as resistant by applying the appropriate breakpoints in a defined phenotypic test system.\]<br/><br/>\[Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).\]</td></tr><tr><td><a href="http://terminology.hl7.org/6.3.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-S">S</a></td><td>Susceptible</td><td>Bacterial strain inhibited by in vitro concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic success. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized\_Terminolo.htm) Synonym (earlier term): Sensitive Projects: ISO 20776-1, ISO 20776-2<br/><br/>\[Note 1: Bacterial strains are categorized as susceptible by applying the appropriate breakpoints in a defined phenotypic system.\]<br/><br/>\[Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).\]</td></tr><tr><td><a href="http://terminology.hl7.org/6.3.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-SYN-S">SYN-S</a></td><td>Synergy - susceptible</td><td>A category for isolates where the bacteria (e.g. enterococci) are susceptible in vitro to a combination therapy (e.g., high-level aminoglycoside and cell wall active agent). This is predictive that this combination therapy will be effective.<br/><br/>*Usage Note:* Since the use of penicillin or ampicillin alone often results in treatment failure of serious enterococcal or other bacterial infections, combination therapy is usually indicated to enhance bactericidal activity. The synergy between a cell wall active agent (such as penicillin, ampicillin, or vancomycin) and an aminoglycoside (such as gentamicin, kanamycin or streptomycin) is best predicted by screening for high-level bacterial resistance to the aminoglycoside.<br/><br/>*Open Issue:* The print name of the code is very general and the description is very specific to a pair of classes of agents, which may lead to confusion of these concepts in the future should other synergies be found.</td></tr><tr><td><a href="http://terminology.hl7.org/6.3.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-SYN-R">SYN-R</a></td><td>Synergy - resistant</td><td>A category for isolates where the bacteria (e.g. enterococci) are not susceptible in vitro to a combination therapy (e.g., high-level aminoglycoside and cell wall active agent). This is predictive that this combination therapy will not be effective.<br/><br/>*Usage Note:* Since the use of penicillin or ampicillin alone often results in treatment failure of serious enterococcal or other bacterial infections, combination therapy is usually indicated to enhance bactericidal activity. The synergy between a cell wall active agent (such as penicillin, ampicillin, or vancomycin) and an aminoglycoside (such as gentamicin, kanamycin or streptomycin) is best predicted by screening for high-level bacterial resistance to the aminoglycoside.<br/><br/>*Open Issue:* The print name of the code is very general and the description is very specific to a pair of classes of agents, which may lead to confusion of these concepts in the future should other synergies be found.</td></tr></table></li></ul></div>

  <p>&#160;</p>
  <a name="expansion"> </a>
  <h3 id="expansion">Expansion</h3>

  <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>ValueSet </b></p><p style="border: black 1px dotted; background-color: #EEEEEE; padding: 8px; margin-bottom: 8px">Expansion performed internally based on <a href="http://terminology.hl7.org/6.3.0/CodeSystem-v3-ObservationInterpretation.html">codesystem ObservationInterpretation v3.0.0 (CodeSystem)</a></p><p>This value set contains 5 concepts</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>System</b></td><td><b>Display (en-US)</b></td><td><b>Definition</b></td></tr><tr><td style="white-space:nowrap"><a name="x-http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation-I"> </a>  <a href="http://terminology.hl7.org/6.3.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-I">I</a></td><td>http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation</td><td>Intermediate</td><td><div><p>Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with uncertain therapeutic effect. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized_Terminolo.htm) Projects: ISO 20776-1, ISO 20776-2</p>
<p>[Note 1: Bacterial strains are categorized as intermediate by applying the appropriate breakpoints in a defined phenotypic test system.]</p>
<p>[Note 2: This class of susceptibility implies that an infection due to the isolate can be appropriately treated in body sites where the drugs are physiologically concentrated or when a high dosage of drug can be used.]</p>
<p>[Note 3: This class also indicates a &quot;buffer zone,&quot; to prevent small, uncontrolled, technical factors from causing major discrepancies in interpretations.]</p>
<p>[Note 4: These breakpoints can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).]</p>
</div></td></tr><tr><td style="white-space:nowrap"><a name="x-http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation-R"> </a>  <a href="http://terminology.hl7.org/6.3.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-R">R</a></td><td>http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation</td><td>Resistant</td><td><div><p>Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic failure. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized_Terminolo.htm) Projects: ISO 20776-1, ISO 20776-2</p>
<p>[Note 1: Bacterial strains are categorized as resistant by applying the appropriate breakpoints in a defined phenotypic test system.]</p>
<p>[Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).]</p>
</div></td></tr><tr><td style="white-space:nowrap"><a name="x-http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation-S"> </a>  <a href="http://terminology.hl7.org/6.3.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-S">S</a></td><td>http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation</td><td>Susceptible</td><td><div><p>Bacterial strain inhibited by in vitro concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic success. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized_Terminolo.htm) Synonym (earlier term): Sensitive Projects: ISO 20776-1, ISO 20776-2</p>
<p>[Note 1: Bacterial strains are categorized as susceptible by applying the appropriate breakpoints in a defined phenotypic system.]</p>
<p>[Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).]</p>
</div></td></tr><tr><td style="white-space:nowrap"><a name="x-http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation-SYN-S"> </a>  <a href="http://terminology.hl7.org/6.3.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-SYN-S">SYN-S</a></td><td>http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation</td><td>Synergy - susceptible</td><td><div><p>A category for isolates where the bacteria (e.g. enterococci) are susceptible in vitro to a combination therapy (e.g., high-level aminoglycoside and cell wall active agent). This is predictive that this combination therapy will be effective.</p>
<p><em>Usage Note:</em> Since the use of penicillin or ampicillin alone often results in treatment failure of serious enterococcal or other bacterial infections, combination therapy is usually indicated to enhance bactericidal activity. The synergy between a cell wall active agent (such as penicillin, ampicillin, or vancomycin) and an aminoglycoside (such as gentamicin, kanamycin or streptomycin) is best predicted by screening for high-level bacterial resistance to the aminoglycoside.</p>
<p><em>Open Issue:</em> The print name of the code is very general and the description is very specific to a pair of classes of agents, which may lead to confusion of these concepts in the future should other synergies be found.</p>
</div></td></tr><tr><td style="white-space:nowrap"><a name="x-http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation-SYN-R"> </a>  <a href="http://terminology.hl7.org/6.3.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-SYN-R">SYN-R</a></td><td>http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation</td><td>Synergy - resistant</td><td><div><p>A category for isolates where the bacteria (e.g. enterococci) are not susceptible in vitro to a combination therapy (e.g., high-level aminoglycoside and cell wall active agent). This is predictive that this combination therapy will not be effective.</p>
<p><em>Usage Note:</em> Since the use of penicillin or ampicillin alone often results in treatment failure of serious enterococcal or other bacterial infections, combination therapy is usually indicated to enhance bactericidal activity. The synergy between a cell wall active agent (such as penicillin, ampicillin, or vancomycin) and an aminoglycoside (such as gentamicin, kanamycin or streptomycin) is best predicted by screening for high-level bacterial resistance to the aminoglycoside.</p>
<p><em>Open Issue:</em> The print name of the code is very general and the description is very specific to a pair of classes of agents, which may lead to confusion of these concepts in the future should other synergies be found.</p>
</div></td></tr></table></div>

  <hr/>
  <p>
    Explanation of the columns that may appear on this page:
  </p>
  <table class="grid">
    <tr>
      <td>Level</td>
      <td>A few code lists that FHIR defines are hierarchical - each code is assigned a level.
          In this scheme, some codes are under other codes, and imply that the code they are under also applies</td>
    </tr>
    <tr>
      <td>System</td>
      <td>The source of the definition of the code (when the value set draws in codes defined elsewhere)</td>
    </tr>
    <tr>
      <td>Code</td>
      <td>The code (used as the code in the resource instance)</td>
    </tr>
    <tr>
      <td>Display</td>
      <td>The display (used in the <i>display</i> element of a <a href="http://hl7.org/fhir/R4/datatypes.html#Coding">Coding</a>). If there is no display, implementers should not simply display the code, but map the concept into their application</td>
    </tr>
    <tr>
      <td>Definition</td>
      <td>An explanation of the meaning of the concept</td>
    </tr>
    <tr>
      <td>Comments</td>
      <td>Additional notes about how to use the code</td>
    </tr>
  </table>

  

  <!-- insert notes if present -->
  



  

</div>
        </div>  <!-- /inner-wrapper -->
      </div>  <!-- /row -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-content -->

  <script type="text/javascript" src="assets/js/jquery.js"> </script>     <!-- note keep space here, otherwise it will be transformed to empty tag -> fails -->
  <script type="text/javascript" src="assets/js/jquery-ui.min.js"> </script>

  <script type="text/javascript" src="assets/js/window-hash.js"> </script>
  <a name="bottom"> </a>
  <div id="segment-footer" igtool="footer" class="segment">  <!-- segment-footer -->
    <div class="container">  <!-- container -->

      <div style="background-color:var(--footer-nav-bg-color)">
        <table style="width:100%">
          <tbody>
            <tr>
              <td style="text-align:left">&#xA0;

                <a href="ValueSet-allergyVerificationStatus-vista.ttl.html">&lt;prev</a>

              </td>
              <td style="text-align:center">
                <a href="#top">top</a>
              </td>
              <td style="text-align:right">&#xA0;

                <a href="ValueSet-AntibioticSensitivityInterpretation-testing.html">next&gt;</a>

              </td>
            </tr>
          </tbody>
        </table>
      </div>

      <div class="inner-wrapper">
        <p>
          IG &#169; 2025 <a style="color:var(--footer-hyperlink-text-color)" href="https://www.va.gov">VA</a>.  Package va.maps#1.5.11 based on <a style="color: var(--footer-hyperlink-text-color)" href="http://hl7.org/fhir/R4/">FHIR 4.0.1</a>. Generated <span title="Thu, May 8, 2025 08:57+0000">2025-05-08</span>
          <br/>
          <span style="color: var(--footer-highlight-text-color)">
                      Links: <a style="color: var(--footer-hyperlink-text-color)" href="toc.html">Table of Contents</a> |
                 <a style="color: var(--footer-hyperlink-text-color)" href="qa.html">QA Report</a>
                 
                
| <a style="color: #81BEF7" target="_blank" href="https://leaf.va.gov/NATIONAL/776/va_fhir_community_of_practice/?a=newform">Propose a change</a>
          </span>
        </p>
      </div>  <!-- /inner-wrapper -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-footer -->
  
  <div id="segment-post-footer" class="segment hidden">  <!-- segment-post-footer -->
    <div class="container">  <!-- container -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-post-footer -->

  <!-- JS and analytics only. -->
  <!-- Bootstrap core JavaScript
  ================================================== -->
  <!-- Placed at the end of the document so the pages load faster -->
  <script type="text/javascript" src="assets/js/bootstrap.min.js"> </script>
  <script type="text/javascript" src="assets/js/respond.min.js"> </script>
  <script type="text/javascript" src="assets/js/anchor.min.js"> </script>
  <script type="text/javascript" src="assets/js/clipboard.min.js"> </script>
  <script type="text/javascript" src="assets/js/clipboard-btn.js"> </script>
  <script type="text/javascript" src="assets/js/anchor-hover.js"> </script>
  <!-- Analytics Below
  ================================================== -->
  </body>
</html>

